Lacy MK - Search Results

1

Revefenacin Area Under the Curve Spirometry in Patients with Moderate to Very Severe COPD.

LeMaster WB, Witenko CJ, Lacy MK, Olmsted AW, Moran EJ, Mahler DA. LeMaster WB, et al. Among authors: lacy mk. Int J Chron Obstruct Pulmon Dis. 2024 Oct 16;19:2299-2308. doi: 10.2147/COPD.S483176. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 39429809 Free PMC article. Clinical Trial.

2

Real-World Clinical Use and Outcomes of Telavancin for the Treatment of Bone and Joint Infections: Results from the Telavancin Observational Use Registry (TOUR™).

Sims CR, Bressler AM, Graham DR, Lacy MK, Lombardi DA, Castaneda-Ruiz B. Sims CR, et al. Among authors: lacy mk. Drugs Real World Outcomes. 2021 Dec;8(4):509-518. doi: 10.1007/s40801-021-00255-6. Epub 2021 May 26. Drugs Real World Outcomes. 2021. PMID: 34041706 Free PMC article.

3

Time Course and Extent of Renal Function Changes in Patients Receiving Treatment for Staphylococcal Pneumonias: An Analysis Comparing Telavancin and Vancomycin from the ATTAIN Trials.

Nogid B, Lacy MK, Jacobs M, Bruss J, Dwyer J. Nogid B, et al. Among authors: lacy mk. Pharmacotherapy. 2018 Oct;38(10):990-998. doi: 10.1002/phar.2165. Epub 2018 Aug 29. Pharmacotherapy. 2018. PMID: 30003567 Free PMC article.

4

Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality.

Lacy MK, Stryjewski ME, Wang W, Hardin TC, Nogid B, Luke DR, Shorr AF, Corey GR, Barriere SL. Lacy MK, et al. Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S87-93. doi: 10.1093/cid/civ536. Clin Infect Dis. 2015. PMID: 26316562 Clinical Trial.

5

Doxycycline for community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections.

Carter MK, Ebers VA, Younes BK, Lacy MK. Carter MK, et al. Among authors: lacy mk. Ann Pharmacother. 2006 Sep;40(9):1693-5. doi: 10.1345/aph.1H084. Epub 2006 Aug 8. Ann Pharmacother. 2006. PMID: 16896018 No abstract available.

6

Nationwide antibiogram analysis using NCCLS M39-A guidelines.

Zapantis A, Lacy MK, Horvat RT, Grauer D, Barnes BJ, O'Neal B, Couldry R. Zapantis A, et al. Among authors: lacy mk. J Clin Microbiol. 2005 Jun;43(6):2629-34. doi: 10.1128/JCM.43.6.2629-2634.2005. J Clin Microbiol. 2005. PMID: 15956376 Free PMC article.

7

Effect of duplicate isolates of methicillin-susceptible and methicillin-resistant Staphylococcus aureus on antibiogram data.

Horvat RT, Klutman NE, Lacy MK, Grauer D, Wilson M. Horvat RT, et al. Among authors: lacy mk. J Clin Microbiol. 2003 Oct;41(10):4611-6. doi: 10.1128/JCM.41.10.4611-4616.2003. J Clin Microbiol. 2003. PMID: 14532191 Free PMC article.

8

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia.

Nicolau DP, McNabb J, Lacy MK, Quintiliani R, Nightingale CH. Nicolau DP, et al. Among authors: lacy mk. Int J Antimicrob Agents. 2001 Jun;17(6):497-504. doi: 10.1016/s0924-8579(01)00329-6. Int J Antimicrob Agents. 2001. PMID: 11397621 Clinical Trial.

9

Moxifloxacin: clinical efficacy and safety.

Culley CM, Lacy MK, Klutman N, Edwards B. Culley CM, et al. Among authors: lacy mk. Am J Health Syst Pharm. 2001 Mar 1;58(5):379-88. Am J Health Syst Pharm. 2001. PMID: 11258173 Review.

10

Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci.

Lacy MK, Tessier PR, Nicolau DP, Nightingale CH, Quintiliani R. Lacy MK, et al. Int J Antimicrob Agents. 2000 Jun;15(1):25-30. doi: 10.1016/s0924-8579(00)00121-7. Int J Antimicrob Agents. 2000. PMID: 10856673 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters